Skip to content
healthcare.dev
Get a free key

Exjade

NDC 0078-0469, deferasirox, tablet, for suspension, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0469
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021882
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0469 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX250 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
0078-0469-150007804691530 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3495a70c-870c-4968-940e-8baea152cf85

Use it

Look up 0078-0469 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0469 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0469. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.